Equities

Win-Partners Co Ltd

3183:TYO

Win-Partners Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)1,263.00
  • Today's Change-5.00 / -0.39%
  • Shares traded7.50k
  • 1 Year change+3.02%
  • Beta0.6025
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments18,16116,77215,573
Total Receivables, Net20,59717,90816,644
Total Inventory2,7022,8132,066
Prepaid expenses------
Other current assets, total6231,179462
Total current assets42,08338,67234,746
Property, plant & equipment, net4,2543,9005,749
Goodwill, net123132--
Intangibles, net253240157
Long term investments677188
Note receivable - long term------
Other long term assets262252237
Total assets47,73043,88341,565
LIABILITIES
Accounts payable21,25618,56916,976
Accrued expenses371369393
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total1,4439461,330
Total current liabilities23,06919,88418,699
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total1,2751,2171,145
Total liabilities24,34421,10119,843
SHAREHOLDERS EQUITY
Common stock550550550
Additional paid-in capital2,3642,2722,272
Retained earnings (accumulated deficit)21,15620,74119,688
Treasury stock - common(778)(836)(836)
Unrealized gain (loss)444241
Other equity, total49136.89
Total equity23,38522,78221,722
Total liabilities & shareholders' equity47,73043,88341,565
Total common shares outstanding292828
Treasury shares - common primary issue1.942.082.08
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.